You are here: All Products  > Eddingpharm Gains China Rights to Cancer Drug from Immutep

Eddingpharm Gains China Rights to Cancer Drug from Immutep

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products